Logo

Paired Ends: Gregory Critchfield

Nov 17, 2011
Premium

Former Myriad Genetic Laboratories president Gregory Critchfield has become CEO of Sera Prognostics, a protein biomarker company. He retired from Myriad and joined Sera's board of directors last year.

Filed under

Clinical Sequencing
Sequencing
Diagnostics
Myriad
Breaking News
The Scan

And Back

The New York Times reports that missing SARS-CoV-2 genome sequences are back in a different database.

Lacks Family Hires Attorney

A lawyer for the family of Henrietta Lacks plans to seek compensation from pharmaceutical companies that have used her cancer cells in product development, the Baltimore Sun reports.

For the Unknown

The Associated Press reports that family members are calling on the US military to use new DNA analysis techniques to identify unknown sailors and Marines who were on the USS Arizona.

PLOS Papers on Congenital Heart Disease, COVID-19 Infection Host MicroRNAs, Multiple Malformation Mutations

In PLOS this week: new genes linked to congenital heart disease, microRNAs with altered expression in COVID-19, and more.